What Is PDGF? The Science Behind Regenerative Growth Factors

PDGF isn’t new science. Its use in aesthetic skin treatments is. Here’s what we know, what we’re still learning, and why it has our attention.

Publish Date:
September 15, 2026

Regenerative Aesthetics Has an Acronym Problem

PRP.

PRF.

PDGF.

Exosomes.

Secretomes.

Growth factors.

If you’re confused, we don’t blame you.

These terms are often used almost interchangeably online, usually underneath the same umbrella of “regenerative aesthetics.”

But they don’t describe the same thing.

And understanding the difference can make you a much more informed patient.

PRP Starts With Your Blood

Platelet-rich plasma, or PRP, begins with a blood draw.

Your blood is processed to create a plasma fraction with a higher concentration of platelets. Those platelets contain and release multiple biologically active substances, including several growth factors.

That makes PRP an autologous treatment, meaning the source material comes from you.

It also means PRP isn’t one perfectly standardized substance.

Its composition can be affected by the patient, collection method, centrifugation protocol, platelet concentration and preparation technique.

That variability is one reason studies of PRP don’t always produce identical results.

PDGF Is Much More Specific

PDGF stands for platelet-derived growth factor.

And yes, PDGF is one of the growth factors associated with platelets.

But using a defined recombinant PDGF-BB preparation is very different from using a patient’s platelet-rich plasma.

One delivers a more complex biological mixture.

The other can deliver a defined signaling protein.

A simple way to think about it is:

PRP = a mixture containing many biologically active components.

PDGF = one specific family of signaling proteins.

Neither description tells you which is “better.”

It tells you that they’re different.

Exosomes Are Different Again

Exosomes are tiny extracellular vesicles involved in communication between cells.

They can carry biological cargo, including proteins, lipids and nucleic acids.

That makes them scientifically fascinating.

But there’s a major problem with the way the word exosome is used commercially:

It can make very different products sound equivalent.

They aren’t.

Exosomes can originate from different cellular sources. Isolation methods can differ. Processing can differ. Characterization can differ. Storage can differ. Delivery methods can differ.

A 2026 scoping review screened 2,394 publications and found only 18 clinical studies specifically examining topical exosomes for skin rejuvenation. The authors found encouraging signals, but also substantial heterogeneity in sources and limited information around processing and shelf life in commercial products.

That’s a very different story from:

“Exosomes are clinically proven.”

And Then There Are Secretomes

Here’s one more distinction worth understanding.

A secretome refers more broadly to the collection of substances released by cells.

Exosomes can be one component of a secretome.

That’s relevant to products such as PROVOQUE, because its manufacturer describes its skin-specific secretome as containing multiple components, including growth factors, naturally occurring exosomes and Fetuin-A.

Staff training advanced.pptx

So even “secretome” and “exosome” aren’t interchangeable terms.

Which Is Best?

That’s probably the most common question.

It’s also not the question we would start with.

We would ask:

Best for what?

What are we treating?

What’s the evidence for this specific formulation?

How is it being used?

What procedure is it being paired with?

What do we know about its source and manufacturing?

And most importantly:

What does this patient actually need?

WHAT THE SCIENCE ACTUALLY SAYS

What we know: PRP, PDGF and extracellular-vesicle technologies all have legitimate biological rationales and varying levels of human research.

What we’re still learning: Preparation and product standardization remain significant challenges, particularly with PRP and exosome-based interventions. Current exosome reviews continue to describe promising short-term findings alongside substantial heterogeneity and limited long-term evidence.

What that means at SKM: The word regenerative isn’t enough for us.

We want to know what’s actually being used and why.

The SKM Rule

When you hear a regenerative claim, ask five questions:

What’s the source?

What’s actually in it?

How was it processed or manufactured?

Has the finished formulation been studied in humans?

Does that evidence actually apply to the way it’s being used?

Those questions won’t make regenerative aesthetics less exciting.

They make it more credible.

EXPLORE REGENERATIVE MICRONEEDLING + PDGF

book now